| Fund | Type | Gross assets | Min. |
|---|---|---|---|
| 4bio Ventures III LP | Private Equity | $154M | $5M |
| 4bio Ventures II LP | Private Equity | $109.6M | $5M |
| 4bio Advanced Therapies Long Equity Fund | Liquidity | $440K | $100K |
| Name | Title | Ownership | Since |
|---|---|---|---|
| Andrey Kozlov Control | Managing Partner | 25-50% | 2021 |
| Dmitry Andrew Kuzmin Control | Managing Partner | 25-50% | 2021 |
| Kieran Mudryy Control | Partner, General Counsel, Chief Compliance Officer | 10-25% | 2021 |
4bio Partners LLP reports $264.5 million in regulatory assets under management on its Form ADV.
4bio Partners LLP manages 4 private funds with combined gross assets of $264.5 million.
4bio Partners LLP reports 3 employees.
4bio Partners LLP is based in London.
4bio Partners LLP is not required to publicly disclose fund returns. Form ADV filings include assets, ownership, and service providers, shown above.
| Address | 20 North Audley Street, London W1K 6WE |
| Office hours | 8:00a.m. - 5:00p.m. |
| Discloses disciplinary history | No |
| Discretionary | $264M |
| Non-discretionary | $440K |
| Total (RAUM) | $264.5M |